top of page

Your Cholesterol Looks Normal. Could Lipoprotein(a) Still Reveal an Inherited Heart Risk?

22 hours ago
5 min read
Older adult discussing lipoprotein(a) and inherited cardiovascular risk with a healthcare professional

A Normal Cholesterol Panel Does Not Tell the Entire Story  


A routine cholesterol test can provide valuable information about cardiovascular health.

But it does not measure everything.


One less familiar marker—lipoprotein(a), or Lp(a)—can identify an inherited cardiovascular risk that may not be obvious from a standard lipid panel.


This has become particularly relevant following the 2026 ACC/AHA dyslipidemia guideline, which recommends measuring Lp(a) at least once in adulthood as part of cardiovascular risk assessment.


The reason is straightforward:

You can have an LDL cholesterol level that appears acceptable and still have an elevated Lp(a).


What Is Lipoprotein(a)?  


Lipoprotein(a) is a particle in the bloodstream that resembles LDL but contains an additional protein called apolipoprotein(a).


Unlike many cardiovascular risk factors, Lp(a) is largely determined by genetics.


The American College of Cardiology estimates that approximately 90% of Lp(a) levels are genetically determined. Levels are also relatively stable throughout life.


This means Lp(a) can provide information about lifelong inherited cardiovascular risk that a standard cholesterol test may not capture.


Why Can Lp(a) Matter When LDL Looks Normal?  


LDL cholesterol and Lp(a) are different measurements.


A standard lipid panel generally includes:


  • LDL cholesterol

  • HDL cholesterol

  • Triglycerides

  • Total cholesterol


It does not automatically include Lp(a).


The American Heart Association specifically notes that someone can have normal LDL cholesterol and still have elevated Lp(a).


This is important because cardiovascular risk is not determined by LDL alone.


The 2026 ACC/AHA guideline now specifically recognizes Lp(a) as a risk-enhancing factor that can help refine cardiovascular risk assessment.


How Much Does an Elevated Lp(a) Matter?  


The 2026 ACC/AHA guideline identifies:


  • ≥125 nmol/L (50 mg/dL): associated with approximately 1.4 times higher ASCVD risk

  • ≥250 nmol/L (100 mg/dL): associated with at least twice the estimated risk


These are risk associations, not predictions that an individual will develop heart disease.


An elevated result therefore does not mean that cardiovascular disease is inevitable.

It means that the person's overall risk profile may deserve a closer look.


Why Is Lp(a) Considered an Inherited Risk?  


Unlike LDL cholesterol, which can be significantly influenced by diet, weight, medications,

and other factors, Lp(a) is primarily genetically determined.


This is why family history can be particularly relevant.


Someone with:


  • Premature heart disease in close relatives

  • A known family history of elevated Lp(a)

  • Unexpected cardiovascular disease despite relatively favorable traditional risk factors


may have additional information to gain from knowing their Lp(a) level.


The 2026 ACC/AHA guideline recommends cascade testing of first-degree relatives in

certain situations involving elevated Lp(a) or inherited lipid disorders.


Why One Test May Be Enough  


Because Lp(a) is largely genetically determined and relatively stable, repeated testing is generally unnecessary for most people.


The new ACC/AHA guideline recommends measuring it at least once during adulthood.


The European Society of Cardiology similarly recommends considering Lp(a) measurement at least once during an adult's lifetime.


This makes Lp(a) different from measurements such as blood pressure or glucose, which can change substantially and may require regular monitoring.


Can Lifestyle Changes Lower Lp(a)?  


This is an important distinction.


Healthy lifestyle habits remain extremely important for cardiovascular health, but they generally have little effect on the Lp(a) concentration itself.


The ACC/AHA guideline notes that lifestyle changes minimally affect Lp(a), which is one reason a single measurement can be useful.


That does not mean lifestyle becomes irrelevant.


If Lp(a) is elevated, controlling other modifiable cardiovascular risk factors becomes particularly important.


That can include:


  • LDL cholesterol

  • Blood pressure

  • Blood glucose

  • Smoking

  • Physical inactivity

  • Excess body weight


The objective is not necessarily to lower the Lp(a) number itself.


It is to reduce the overall cardiovascular risk associated with it.


What Happens If Lp(a) Is High?  


An elevated Lp(a) result does not automatically mean that a person needs a specific Lp(a)-lowering medication.


Currently, clinical management generally focuses on addressing the cardiovascular risk factors that can be modified.


The ACC notes that elevated Lp(a) can support earlier or more intensive management of LDL cholesterol and other modifiable risk factors.


This distinction is important because Lp(a) testing is primarily a risk-assessment tool.


It does not by itself establish that someone has coronary artery disease.


Lp(a) Is Only One Part of the Risk Picture  


An elevated Lp(a) should not be interpreted in isolation.


A clinician may also consider:


  • Age

  • Blood pressure

  • LDL and non-HDL cholesterol

  • Diabetes

  • Kidney function

  • Smoking

  • Family history

  • Physical activity

  • Existing cardiovascular disease

  • Other risk-enhancing factors


The 2026 ACC/AHA guideline also recognizes additional tools such as apolipoprotein B (apoB) and selective coronary artery calcium (CAC) scoring when additional information is needed to refine cardiovascular risk.


Not everyone needs these tests.


The appropriate approach depends on the individual's overall risk profile.


What If Your Cholesterol Already Looks Good?  


This is where Lp(a) can be particularly interesting.


A person might have:


LDL: within an acceptable range

Blood pressure: well controlled

Blood sugar: normal

No smoking history: Yet they may still have an inherited elevation in Lp(a).


That does not mean something is wrong.


It means the standard measurements may not capture every factor influencing lifetime cardiovascular risk.


This is one reason modern cardiovascular prevention is moving toward a more comprehensive risk assessment rather than relying on a single cholesterol number.


Should Everyone Have Lp(a) Tested?  


The answer has changed.


The 2026 ACC/AHA guideline recommends measuring Lp(a) at least once in all adults for cardiovascular risk assessment.


Testing may be particularly informative when there is:


  • Premature cardiovascular disease in the family

  • A known family history of elevated Lp(a)

  • Cardiovascular disease that seems disproportionate to traditional risk factors

  • Familial hypercholesterolemia

  • Uncertainty about overall cardiovascular risk


The test is generally a blood test and is separate from the standard lipid panel.


The Bigger Lesson: Risk Can Be Inherited Without Being Obvious  


One of the most useful aspects of Lp(a) testing is that it illustrates how cardiovascular risk can operate beneath the surface.


Someone may feel healthy.


Their routine cholesterol panel may look reassuring.


Their lifestyle may be strong.


Yet genetics can still contribute to long-term cardiovascular risk.


This does not mean genetics determine destiny.


It means inherited information can help explain why two people with similar conventional cholesterol levels may have different overall risk profiles.


Conclusion  


A normal cholesterol panel is useful information—but it is not the entire cardiovascular picture.


Lipoprotein(a) provides a different type of information.


Because Lp(a) is largely inherited and relatively stable, an elevated level can identify a risk factor that may otherwise remain hidden. The 2026 ACC/AHA guideline now recommends that adults have Lp(a) measured at least once.


An elevated result does not mean that heart disease is inevitable, nor does it automatically require medication specifically targeting Lp(a).


Instead, it can provide another piece of information for understanding lifetime cardiovascular risk and deciding how aggressively other modifiable risk factors should be managed.


Knowing your LDL is important. Knowing whether inherited Lp(a) risk is also present may provide a more complete picture.


Trusted References  


  • American College of Cardiology / American Heart Association — 2026 Guideline on the Management of Dyslipidemia.

  • American Heart Association — Lp(a): Myths and Facts.

  • American College of Cardiology — Lp(a) Assessment and Management: A Clinician's Guide.

  • European Society of Cardiology / European Atherosclerosis Society — 2025 Focused Update of the Dyslipidaemia Guidelines.

  • American College of Cardiology — Primary Prevention in a Patient With an Elevated Lp(a) Level, 2026.

 
 
 

Comments


Eastside Longevity Clinic Logo

Start your Longevity Journey Today!

425-899-2525

11415 Slater Avenue NE
Suite 102, Kirkland, WA 98033

Message Us for More Information

© 2026 by Eastside Longevity Clinic.

bottom of page